NCT00623831 2022-10-25A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenLudwig Institute for Cancer ResearchPhase 1 Completed17 enrolled 14 charts
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled